by John Walsh PA CDE and Timothy Bailey MD FACE CPI
by John Walsh PA CDE and Timothy Bailey MD FACE CPI
by John Walsh PA CDE, Dariusz Wroblewski PhD, and Timothy S. Bailey MD FACE CPI - -
12/18/08 - ,
designed to improve insulin pump use and medical outcomes. Comments and suggestions on these guidelines are welcomed. Please view the and step over to our and leave your comments. Be patient -- there are 29 proposed features presented over 157 slides.12/03/08 ( or ), 11/10/08 ( or ) and 10/10/08 ( or ).
or downloadable . or download the . or the downloadable . . You can also download the . Be sure to comment on this presentation or read others' comments in our . or downloading the . Be sure to comment or read others' comments about this study in our . or download the details new insulin pump ideas to improve glucose levels, avoid hypoglycemia, and speed correction of hyperglycemia. details the idea of a "Smart Pen" that demonstrates the possibilities for intelligent diabetes devices. You can discuss this device in our . details the best tips, tricks, and methods to accurately count carb. You can also download the . . You can also download the . details a number of ways to prevent and treat hypoglycemia. You can also download the . in this helpful PDF presentation.The following presentations provide a multifaceted review of topics relating to diabetes. Overviews of Type 1 and Type 2 diabetes, metabolic syndrome, and gestational diabetes (diabetes developing during pregnancy) are discussed. In addition, complications associated with both forms of diabetes are discussed along with measures to lower the risk for these complications. The importance of monitoring maternal glucose in relation to infant growth and development is also discussed.
The presentation will download as a Powerpoint software file when you click on the title in the link.
Metabolic Basis of Disease Center
Institute for Dementia Research & Prevention
Louisiana Clinical & Translational Science Center
Nutrition Obesity Research Center
Metamor Institute
Center for Military Performance & Resilience
Childhood Obesity and Diabetes Research
Human Research Protections Program
Research Kitchen + Recipes
Greaux Healthy
Business Development
LAUNCHED Program
Pennington Biomedical Research Foundation
Obesity Society
American Diabetes Association
6400 Perkins Rd. Baton Rouge, LA 70808 ph: (225) 763-2500 fax: (225) 763-3022
© Copyright Pennington Biomedical Research Center
Customize the Diabetes presentation template for PowerPoint & Google Slides to present your diabetes awareness presentations comprehensively. Diabetes is a chronic disease that alters the normal glucose level of the body and can lead to various complications. The major cause of diabetes is the decreased production of insulin. The prevalence of this disease is more than ever, and it’s crucial to understand the causes and risk factors associated with diabetes. We have specifically designed this interactive PowerPoint template for social workers, healthcare experts, and doctors. So that they can create useful presentations for the audience while accomplishing diabetes awareness campaigns. November is National Diabetes Month, and it is important to educate the public about diabetes.
Our Diabetes presentation template can also be used in executive sessions to present support for diabetes funding, research, and awareness. The title slide contains the diagram of a glucometer connected with a blue diabetes support ribbon. The further slides contain human illustrations with a diagram of the glucometer, pricker, and test strips, which can help the audience understand safe sugar levels and risky conditions. Moreover, in the following slide, a weighing balance shows that the significance of fruits is higher than fast food. Some other slides are:
This creative diabetes template is compatible with all versions of Microsoft PowerPoint, Google Slides, and Keynote. The users can change the slides’ colors, relevant graphical elements, icons, and theme according to their preferences. So, download this useful PPT template and make amazing presentations in the diabetes month of November. Alternatively, you can download the Diabetes PPT template design with other useful slides that you can use in your presentation on diabetes topics.
You must be logged in to download this file.
Favorite Add to Collection
Subscribe today and get immediate access to download our PowerPoint templates.
Diabetes prevention: 5 tips for taking control.
Changing your lifestyle could be a big step toward diabetes prevention — and it's never too late to start. Consider these tips.
Lifestyle changes can help prevent the onset of type 2 diabetes, the most common form of the disease. Prevention is especially important if you're currently at an increased risk of type 2 diabetes because of excess weight or obesity, high cholesterol, or a family history of diabetes.
If you have been diagnosed with prediabetes — high blood sugar that doesn't reach the threshold of a diabetes diagnosis — lifestyle changes can prevent or delay the onset of disease.
Making a few changes in your lifestyle now may help you avoid the serious health complications of diabetes in the future, such as nerve, kidney and heart damage. It's never too late to start.
Losing weight reduces the risk of diabetes. People in one large study reduced their risk of developing diabetes by almost 60% after losing approximately 7% of their body weight with changes in exercise and diet.
The American Diabetes Association recommends that people with prediabetes lose at least 7% to 10% of their body weight to prevent disease progression. More weight loss will translate into even greater benefits.
Set a weight-loss goal based on your current body weight. Talk to your doctor about reasonable short-term goals and expectations, such as a losing 1 to 2 pounds a week.
There are many benefits to regular physical activity. Exercise can help you:
Goals for most adults to promote weight loss and maintain a healthy weight include:
Plants provide vitamins, minerals and carbohydrates in your diet. Carbohydrates include sugars and starches — the energy sources for your body — and fiber. Dietary fiber, also known as roughage or bulk, is the part of plant foods your body can't digest or absorb.
Fiber-rich foods promote weight loss and lower the risk of diabetes. Eat a variety of healthy, fiber-rich foods, which include:
The benefits of fiber include:
Avoid foods that are "bad carbohydrates" — high in sugar with little fiber or nutrients: white bread and pastries, pasta from white flour, fruit juices, and processed foods with sugar or high-fructose corn syrup.
Fatty foods are high in calories and should be eaten in moderation. To help lose and manage weight, your diet should include a variety of foods with unsaturated fats, sometimes called "good fats."
Unsaturated fats — both monounsaturated and polyunsaturated fats — promote healthy blood cholesterol levels and good heart and vascular health. Sources of good fats include:
Saturated fats, the "bad fats," are found in dairy products and meats. These should be a small part of your diet. You can limit saturated fats by eating low-fat dairy products and lean chicken and pork.
Many fad diets — such as the glycemic index, paleo or keto diets — may help you lose weight. There is little research, however, about the long-term benefits of these diets or their benefit in preventing diabetes.
Your dietary goal should be to lose weight and then maintain a healthier weight moving forward. Healthy dietary decisions, therefore, need to include a strategy that you can maintain as a lifelong habit. Making healthy decisions that reflect some of your own preferences for food and traditions may be beneficial for you over time.
One simple strategy to help you make good food choices and eat appropriate portions sizes is to divide up your plate. These three divisions on your plate promote healthy eating:
The American Diabetes Association recommends routine screening with diagnostic tests for type 2 diabetes for all adults age 45 or older and for the following groups:
Share your concerns about diabetes prevention with your doctor. He or she will appreciate your efforts to prevent diabetes and may offer additional suggestions based on your medical history or other factors.
There is a problem with information submitted for this request. Review/update the information highlighted below and resubmit the form.
Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.
Error Email field is required
Error Include a valid email address
To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.
You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
Please, try again in a couple of minutes
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press .
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.
Get Support – Call 1-888-MITO-411
Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease
Join Dr. McCormack and Dr. Guzman as they review and discuss the causes of high and low blood sugars in mitochondrial Related to the mitochondria. disease, while also providing important updates on mitochondrial diabetes and hypoglycemia Low blood sugar. management.
Faod monthly evening support call, weekly support call, expert series: mitochondrial disease and pmm, expert series, last presentation.
Expert Series: Mitochondrial Disease and PMM Presented September 11, 2024
P.O. Box 310 Novi, MI 48376 (888) 648-6228 [email protected]
Diabetes mellitus is the most common pediatric endocrinal disorder. Diabetic ketoacidosis is one of the most serious life-threatening complications and might be the initial presentation. Poor management, non-compliance and infection are the main triggers for DKA. Infection leads to activation of the hypothalamic-pituitary-adrenal axis leading to the production of cortisol, sometimes excessively which might affect the illness course.
The study aimed to measure basal serum cortisol levels during DKA as a significant predictor of DKA duration and to assess the time to recovery between children with newly diagnosed diabetes compared with known diabetics presenting with and without infection.
This cross-sectional study included 207 pediatric patients presenting with DKA where serum cortisol level was measured on admission.
The mean cortisol level was 41.54 µg/dl ± 21.36 µg/dL. Cortisol levels were inversely associated with serum pH and bicarbonate level with (r = -0.544; p = <0.001) and ( r = -0.520; p = <0.001) respectively. There was a positive association of cortisol levels with the duration of DKA (r = 0.443; p = <0.001). Thirty-four children (16.40%) with cortisol levels < 18 µg/dL showed higher serum pH, and bicarbonate levels and shorter duration of DKA with a statistically significant p value <0.001. One-hundred and fourteen (55.1%) patients with cortisol levels >34 µg/dL had lower pH, bicarbonate level, and longer duration of DKA with a statistically significant p value <0.001.
Cortisol levels on admission higher than 34 µg/dL are associated with a longer duration of DKA while levels lower than 18 ug/dl were associated with a significantly shorter duration. Therefore, it’s recommended to measure basal serum cortisol levels on admission during DKA as significant predictor to DKA duration.
This is a preview of subscription content, log in via an institution to check access.
Subscribe and save.
Price includes VAT (Russian Federation)
Instant access to the full article PDF.
Rent this article via DeepDyve
Institutional subscriptions
Comparison of total, salivary and calculated free cortisol levels in patients with severe sepsis.
Data availability.
Data will be available upon reasonable request.
Bechman Coulter, Inc. 250 South Kraemer, Boulevard, Brea, CA 92821, USA.
Roche Diagnostics GmbH, Sand Hofer Strasse 116, D-68305 Mannheim.
Diabetic Ketoacidosis
Diabetes, Endocrine and Metabolism Pediatric Unit
Standard Deviation
Adrenocorticotrophic
American Diabetes Association. Comprehensive medical evaluation and assessment of comorbidities (2021) Standards of Medical Care in Diabetes 44(suppl 1): S40-S52. https://doi.org/10.2337/dc21-S004.
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, Aschner P, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl. 27):7–19. https://doi.org/10.1111/pedi.12773 .
Article PubMed PubMed Central Google Scholar
Jackson W, Hofman PL, Robinson EM, Elliot RB, Pilcher CC, Cutfield WS. The changing presentation of children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2001;2:154–9. https://doi.org/10.1034/j.1399-5448.2001.20403.x .
Article CAS PubMed Google Scholar
Onyiriuka AN, Ifebi E. Ketoacidosis at diagnosis of type 1diabetes in children and adolescents: frequency and clinical characteristics. J Diabetes Metab Disord. 2013;12:47. https://doi.org/10.1186/2251-6581-12-47 .
Article CAS PubMed PubMed Central Google Scholar
Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents. Diabetes Care. 2006;29:1150–9. https://doi.org/10.2337/diacare.2951150 .
Article PubMed Google Scholar
Mahmud FH, Elbarbary NS, Fröhlich- Reiterer E, Holl RW, Kordonouri O, Knip M, Simmons K, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018;19(Suppl. 27):275–86. https://doi.org/10.1111/pedi.13445 .
Klingensmith GJ, Tamborlane WV, Wood J, Haller MJ, Silverstein J, Cengiz E, Shanmugham S, Kollman C, Wong-Jacobson S, Beck RW; Pediatric Diabetes Consortium. Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. J Pediatr. 2013;162(2):330–4.e1. https://doi.org/10.1016/j.jpeds.2012.06.058
Smuel-Zilberberg K, Shalitin S, Yackobovitch-Gavan M, Phillip M, Nimri R. Diabetes ketoacidosis recovery in youth with newly diagnosed and established type 1 diabetes. Pediatr Res. 2022;91(5):1272–7. https://doi.org/10.1038/s41390-021-01618-z .
Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. 2019;15(9):525–34. https://doi.org/10.1038/s41574-019-0228-0 .
Langer M, Modi BP, Agus M. Adrenal insufficiency in the critically ill neonate and child. Curr Opin Pediatr. 2006;18:448–53. https://doi.org/10.1097/01.mop.0000236397.79580.85 .
Schuetz P, Müller B. The hypothalamic-pituitary-adrenal axis in critical illness. Endocrinol Metab Clin North Am. 2006;35(4):823–38, x. https://doi.org/10.1016/j.ecl.2006.09.013
Glaser N, Fritsch M, Priyambada, L, Rewers A, Cherubini V, Estrada S. Wolfsdorf JI, Codner E (2022) ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatric diabetes 23(7), 835–856. https://doi.org/10.1111/pedi.13406.
Chan YH. Biostatistics102: Quantitative Data – Parametric and Non-parametric Tests. Singapore Med J. 2003;44(8):391–6.
CAS PubMed Google Scholar
Chan YH. Biostatistics 103: Qualitative Data –Tests of Independence. Singapore Med J. 2003;44(10):498–503.
Chan YH. Biostatistics 104: Correlational Analysis. Singapore Med J. 2003;44(12):614–9.
Dhand NK, Khatkar MS. Statulator: An online statistical calculator. Sample Size Calculator for Estimating a Single Mean. 2014. http://statulator.com/SampleSize/ss1M.html . Accessed 1 Jan 2022.
Williams KM, Fazzio P, Oberfield SE, Gallagher MP, Aranoff GS. Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus: A Retrospective Review. Clinical Pediatric. 2017;56(2):117–22. https://doi.org/10.1177/0009922816684595 .
Article Google Scholar
Lipman TH, Levitt Katz LE, Ratcliffe SJ, Murphy KM, Aguilar A, Rezvani I, Howe CJ, Fadia S, Suarez E. Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care. 2013;36(6):1597–603. https://doi.org/10.2337/dc12-0767 .
Group TS. The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann N Y Acad Sci. 2008;1150:1–13. https://doi.org/10.1196/annals.1447.062 .
Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY, Jefferies CA, Oram RA, Dabelea D, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160–74. https://doi.org/10.1111/pedi.13454 .
Al-Ghamdi AH, Fureeh AA. Prevalence and clinical presentation at the onset of type 1 diabetes mellitus among children and adolescents in AL-Baha region. Saudi Arabia J Pediatr Endocrinol Metab. 2018;31(3):269–73. https://doi.org/10.1515/jpem-2017-0059 .
Roche EF, Menon A, Gill D, Hoey H. Clinical presentation of type 1 diabetes. Pediatr Diabetes. 2005;6(2):75–8. https://doi.org/10.1111/j.1399-543X.2005.00110.x .
Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hebert PC; Canadian Critical Care Trials Group (2010) A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 182:246-251. https://doi.org/10.1164/rccm.200911-1738OC.
Levy-Shraga Y, Pinhas-Hamiel O, Molina-Hazan V, et al. Elevated Baseline Cortisol Levels Are Predictive of Bad Outcomes in Critically Ill Children. Pediatr Emerg Care. 2018;34(9):613–7. https://doi.org/10.1097/PEC.0000000000000784 .
Morales J, Palmer BF. Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review. Postgrad Med. 2024. https://doi.org/10.1080/00325481.2024.2316572.
Download references
Yomna Ahmed Hosni
Present address: The Diabetes Endocrine and Metabolism Pediatric Unit, Abo ELReesh Children’s Hospital, Faculty of Medicine Organization, Cairo University, Cairo, Egypt
Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University Cairo, Hosny Othman Sefrat District, Nasr City, Cairo, Egypt
Mai Ali Sayed Abd El Ghaney
You can also search for this author in PubMed Google Scholar
Mai Ali Sayed Abd El Ghaney: shared in study design, revising the article, and statistical analysis of data, writing the manuscript, and final revision of the version to be published.
All authors have made a significant contribution to this manuscript, have seen and approved the final manuscript, and have agreed to its submission.
Yomna Ahmed Hosni: shared in study design, critical revision of the article, interpretation of data, statistical analysis, drafting and writing a manuscript, and final revision of the version to be published.
Correspondence to Mai Ali Sayed Abd El Ghaney .
Conflict of interest.
There are no conflicts of interest to declare.
The study protocol was approved by the Ethical committee and complied with the Declaration of Helsinki. Patients were screened for their eligibility to participate in the study and informed consent was obtained.
Publisher's note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Diabetes mellitus is a chronic complex metabolic disease in children requiring continuous medical care to decrease the possibility of lifelong complications. The initial presentation of diabetes is usually in the form of polyuria, polydipsia, enuresis, weight loss, or polyphagia. In addition, diabetes may present in its most critical form, ketosis or non-ketotic hyperosmolar syndrome. Unfortunately, this may lead to stupor, coma, and death if not promptly treated.
Diabetic ketoacidosis (DKA) is the presentation of more than half of the patients with type 1 diabetes mellitus (T1DM). DKA results in a rise of the proinflammatory markers, and oxidative stress and subsequently increases morbidity and mortality risk. Patients with type 1 diabetes are 25% more prone to develop autoimmune diseases. The most common are autoimmune thyroid disease, celiac disease, and primary adrenal insufficiency.
Many risk factors behind DKA in newly diagnosed individuals with T1DM as the absence of a family history of T1DM, low socioeconomic class younger age, and delayed diagnosis. On the contrary, DKA can occur in known diabetic patients due to several causes such as poor compliance to insulin intake, infection, dysfunction of the insulin pump, and dehydration.
Acute physical insult to the body, for example, febrile illness, poses a threat to survival and well-being. That initiates a physiological response to maintain homeostasis together with complex interactions between the immune and autonomic nervous systems. This activates the hypothalamic–pituitary–adrenal axis leading to the production of cortisol. An increase in the cortisol level occurs as a result of illness and stress to adjust the tone of the blood vessels, cardiac function, and the immune response.
Several studies have shown a positive correlation between serum total cortisol and the severity of critical illness as well as the risk of death. So, this study aimed to measure serum cortisol levels during DKA as significant predictors of DKA duration & to assess the time to recovery from (DKA) between children newly diagnosed with diabetes compared with known diabetics.
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Reprints and permissions
Abd El Ghaney, M.A.S., Hosni, Y.A. Basal serum cortisol levels; significant predictors to DKA duration. Int J Diabetes Dev Ctries (2024). https://doi.org/10.1007/s13410-024-01392-8
Download citation
Received : 23 February 2024
Accepted : 21 August 2024
Published : 10 September 2024
DOI : https://doi.org/10.1007/s13410-024-01392-8
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
COMMENTS
Type 2 Diabetes Warning Signs. Warning Signs and Symptoms - Can occur slowly over time. Blurred vision. Tingling or numbness in legs, feet or fingers. Recurring skin, gum or urinary tract infections. Drowsiness. Slow healing of cuts and bruises. Any symptoms that occur with Type 1 diabetes. Impact of Sugary Foods and.
This comprehensive slide deck of ADA's 2023 Standards of Care contains content created, reviewed, and approved by the American Diabetes Association. You are free to use the slides in presentations without further permission as long as the slide content is not altered in any way and appropriate attribution is made to the American Diabetes Association (the Association name and logo on the slides ...
This topic will review the clinical presentation, diagnosis, and initial evaluation of diabetes in nonpregnant adults. Screening for and prevention of diabetes, the etiologic classification of diabetes mellitus, the treatment of diabetes, as well as diabetes during pregnancy are discussed separately. (See "Screening for type 2 diabetes mellitus".)
This comprehensive slide deck of ADA's 2024 Standards of Care (.PPTX) contains content created, reviewed, and approved by the ADA. You are free to use the slides in presentations without further permission as long as the slide content is not altered in any way and appropriate attribution is made to the American Diabetes Association (the ADA name and logo on the slides constitutes appropriate ...
One of the most surprising things about type 2 diabetes is that you can avoid it. To lower your risk, follow the same guidelines for warding off heart disease: Eat a healthy diet. Exercise for 30 ...
Slide Show: Understanding Type 2 Diabetes. This slide show describes the metabolic disorder of type 2 diabetes and the role of glucose used by the cells of the body. It explains how food is broken down into nutrient molecules that are absorbed in the digestive tract for use by the body and the role of the pancreas and insulin.
Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. ... Presentation History. The diagnosis of diabetes mellitus is readily entertained when a patient ...
This list of presentations is designed to be a resource for people with diabetes, health care professionals, diabetes educators, and students. These presentations can be downloaded but the original authors should be referenced if used elsewhere. To download, right-click the link and choose "Save Link As" to download the PDFs.
Diabetes mellitus is a chronic heterogeneous metabolic disorder with complex pathogenesis. It is characterized by elevated blood glucose levels or hyperglycemia, which results from abnormalities in either insulin secretion or insulin action or both. Hyperglycemia manifests in various forms with a varied presentation and results in carbohydrate ...
Type 1 Diabetes. Previously called "insulin dependent diabetes" or "juvenile-onset diabetes". Develops when the immune system destroys pancreatic beta cells and the rate of beta cell destruction is variable. 5-10% of the U.S. population diagnosed with Diabetes have type 1 (CDC 2018)1. Multiple genetic predispositions.
There are three types of diabetes: type 1, type 2, and gestational diabetes (diabetes you have when you're pregnant). What is type 2 diabetes? In type 2 diabetes, your body has trouble using the insulin it's making. This is called insulin resistance and it causes your blood sugar to rise higher than normal.
Causes. Type 2 diabetes is mainly the result of two problems: Cells in muscle, fat and the liver become resistant to insulin As a result, the cells don't take in enough sugar. The pancreas can't make enough insulin to keep blood sugar levels within a healthy range. Exactly why this happens is not known.
Happy World Diabetes Day! Celebrate World Diabetes Day in style with our fully editable Google Slides and PowerPoint template. Complete with illuminating light green design and vivid photographs, it provides a perfect platform to give an informative presentation about diabetes, its varied types, and summarize significant research.
Older People and Diabetes Stats. 26% of Americans age 65 or older have diabetes (11.8 million seniors) 50% of people with diabetes, 65 yrs plus. 50% of older adults have prediabetes Rate of older population with diabetes growing rapidly due to increasing life expectancy. Diabetes prevalence to double in next 20 years, in part due to the aging ...
More than 133 million Americans have diabetes or prediabetes. 1. As of 2019, 37.3 million people—or 11.3% of the U.S. population—had diabetes. 1 More than 1 in 4 people over the age of 65 had diabetes. Nearly 1 in 4 adults with diabetes didn't know they had the disease. 2. About 90% to 95% of diabetes cases are type 2 diabetes. 3
The Diabetes PowerPoint Template has 13 slides of high-quality vector graphics. This is a presentation tool to discuss diabetes and related topics in ways that are most appealing to the audience. Such as shapes and graphics demonstrating a body diagram, test device, and data charts. Furthermore, the diabetes PowerPoint presentation is a ...
Diabetes Presentations. This list of presentations is designed to be a resource for people with diabetes, health care professionals, diabetes educators, and students. These presentations can be downloaded but the original authors should be referenced if used elsewhere. Take a look at presentations by:
Diabetes. The following presentations provide a multifaceted review of topics relating to diabetes. Overviews of Type 1 and Type 2 diabetes, metabolic syndrome, and gestational diabetes (diabetes developing during pregnancy) are discussed. In addition, complications associated with both forms of diabetes are discussed along with measures to ...
Customize the Diabetes presentation template for PowerPoint & Google Slides to present your diabetes awareness presentations comprehensively. Diabetes is a chronic disease that alters the normal glucose level of the body and can lead to various complications. The major cause of diabetes is the decreased production of insulin. The prevalence of ...
Diabetes Professionals | American Diabetes Association
Limited inactivity. Breaking up long bouts of inactivity, such as sitting at the computer, can help control blood sugar levels. Take a few minutes to stand, walk around or do some light activity every 30 minutes. 3. Eat healthy plant foods. Plants provide vitamins, minerals and carbohydrates in your diet.
Join Dr. McCormack and Dr. Guzman as they review and discuss the causes of high and low blood sugars in mitochondrial Related to the mitochondria. disease, while also providing important updates on mitochondrial diabetes and hypoglycemia Low blood sugar. management.
Background Diabetes mellitus is the most common pediatric endocrinal disorder. Diabetic ketoacidosis is one of the most serious life-threatening complications and might be the initial presentation. Poor management, non-compliance and infection are the main triggers for DKA. Infection leads to activation of the hypothalamic-pituitary-adrenal axis leading to the production of cortisol, sometimes ...
Effect of Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor, on Continuous Glucose Monitoring in Basal Insulin-Treated Type 2 Diabetes - an ePoster presentation, Thursday, September 12 th, 12:45p.m ...
23. Tratamiento CAD - EHNNC Tratamiento CAD - EHNNC Glicemia horaria, pH y gases cada 2 Glicemia horaria, pH y gases cada 2 horas horas Al disminuir glicemia se debe Al disminuir glicemia se debe mantener aporte calórico. Paciente mantener aporte calórico. Paciente en estado de ayuno. Objetivo 200 a en estado de ayuno. Objetivo 200 a 300 mg/dl 300 mg/dl Adulto 5 gr de glucosa/hora Adulto 5 ...